- Home
- INM vs ADTX Comparison
INM vs ADTX Comparison
Compare INM & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- ADTX
- Stock Information
- Founded
- INM 1981
- ADTX 2017
- Country
- INM Canada
- ADTX United States
- Employees
- INM N/A
- ADTX N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- ADTX Health Care
- Exchange
- INM Nasdaq
- ADTX Nasdaq
- Market Cap
- INM 3.2M
- ADTX 3.1M
- IPO Year
- INM N/A
- ADTX 2020
- Fundamental
- Price
- INM $2.75
- ADTX $1.19
- Analyst Decision
- INM
- ADTX
- Analyst Count
- INM 0
- ADTX 0
- Target Price
- INM N/A
- ADTX N/A
- AVG Volume (30 Days)
- INM 5.7M
- ADTX 2.0M
- Earning Date
- INM 05-12-2025
- ADTX 08-18-2025
- Dividend Yield
- INM N/A
- ADTX N/A
- EPS Growth
- INM N/A
- ADTX N/A
- EPS
- INM N/A
- ADTX N/A
- Revenue
- INM $4,920,990.00
- ADTX $55,323.00
- Revenue This Year
- INM N/A
- ADTX $15,768.94
- Revenue Next Year
- INM N/A
- ADTX N/A
- P/E Ratio
- INM N/A
- ADTX N/A
- Revenue Growth
- INM N/A
- ADTX N/A
- 52 Week Low
- INM $1.72
- ADTX $1.05
- 52 Week High
- INM $15.70
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- INM 46.31
- ADTX 38.91
- Support Level
- INM $2.66
- ADTX $1.05
- Resistance Level
- INM $2.97
- ADTX $1.35
- Average True Range (ATR)
- INM 0.37
- ADTX 0.20
- MACD
- INM -0.05
- ADTX 0.03
- Stochastic Oscillator
- INM 15.12
- ADTX 14.91
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.